irAE Prediction of Anti-PD-1/L1 in Lung Cancer

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Related documents

• PD-L1 Expression in Cancer (PECan Study).#394763
• Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer#803804
• Heterogeneity of macrophages in PD-1/PD-L1 inhibitor therapy: a single-cell perspective.#288709
• Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone in stage IIIB-IV squamous non-small cell lung cancer: a systematic review and meta-analysis of phase 3 randomized controlled trials.#685551
• Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types#863388